Table 2.
Factors affecting the cases of albuminuria in T2DM patients on ACEIs or ARBs.
| Variable | p value | OR | 95% CI | ||
|---|---|---|---|---|---|
| Upper | Lower | ||||
| Crude model | RAS inhibitor | ||||
| ACEI | Reference | ||||
| ARB | 0.830 | 1.079 | 0.538 | 2.164 | |
| Adjusted model 1 | RAS inhibitor | ||||
| ACEI | Reference | ||||
| ARB | 0.849 | 1.085 | 0.466 | 2.527 | |
| Sex | |||||
| Male | Reference | ||||
| Female | 0.069 | 0.463 | 0.202 | 1.063 | |
| Diastolic blood pressure | |||||
| Controlled | Reference | ||||
| Uncontrolled | 0.045∗ | 4.964 | 1.033 | 23.863 | |
| Adjusted model 2 | Sex | ||||
| Male | Reference | ||||
| Female | 0.068 | 0.461 | 0.201 | 1.058 | |
| Diastolic blood pressure | |||||
| Controlled | Reference | ||||
| Uncontrolled | 0.046∗ | 4.897 | 1.026 | 23.366 | |
ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin II receptor blockers. ∗Statistically significant.